OM1 Unveils Patented, AI-powered Platform to Accelerate Personalized Medicine

OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligen...

April 13, 2023 | Thursday | News
ZyVersa Publishes Review Article on Targeting Microglial Inflammation in Alzheimer's Disease

During aging, the central nervous system (“CNS”) becomes more inflammatory, leading to activation of microglia (“CNS immune cells&rdquo...

April 13, 2023 | Thursday | News
Evaxion and Pennsylvania State University publish preclinical data validating our AI-based viral vaccine discovery platform

The published data showcase how Evaxion's proprietary AI-platform, RAVEN (Rapidly Adaptive Viral Response), identifies broad and robust T-cell epitopes fro...

April 13, 2023 | Thursday | News
Agilent & PathAI to Provide AI-Based Assay Solutions for Biopharma Applications

Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with PathAI, a leading provider of AI-powered research tools and serv...

April 13, 2023 | Thursday | News
From tragedy, a potential pediatric cancer treatment

Cold Spring Harbor Laboratory Professor Adrian Krainer is best known for his groundbreaking research on antisense oligonucleotides (ASOs)—m...

April 13, 2023 | Thursday | News
Fusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Jointly Developed Novel Targeted Alpha Therapy

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medic...

April 13, 2023 | Thursday | Regulatory
Regulus Therapeutics Completes Enrollment in Phase 1b MAD Trial of RGLS8429 for ADPKD Treatment

"Completion of enrollment in the first cohort of the Phase 1b MAD study is an important milestone in the development of this novel treatment for ADPKD," sa...

April 13, 2023 | Thursday | News
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023

To participate, call 833-470-1428 within the U.S. or +1 929-526-1599 outside the U.S., access code: 522530. A live webcast of the conference call will also...

April 13, 2023 | Thursday | News
Sana Biotech's Hypoimmune Pancreatic Cells Control Type 1 Diabetes in Preclinical Model

Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by the im...

April 13, 2023 | Thursday | News
RxToolKit and NeuroNet Pro Announce Partnership to Improve Clinical Education and Safety for Neurology Practices

This collaboration extends preferred pricing on RxToolKit's software solutions in addition to other exclusive benefits already available to NeuroNet Pro me...

April 12, 2023 | Wednesday | News
Karmanos Cancer Institute invests in software to identify and manage patients at high risk of developing breast cancer

The Barbara Ann Karmanos Cancer Institute, a leading breast cancer prevention and care provider, has adopted Volpara® Risk Pathways™, a market-le...

April 12, 2023 | Wednesday | News
Cognizant and Boehringer Ingelheim Collaborate on Unified Cloud Platform to Speed the Delivery of Life Saving Therapies

Cognizant (NASDAQ: CTSH) announced it is working with Boehringer Ingelheim, a leading research-driven biopharmaceutical company, to advance the speed and q...

April 12, 2023 | Wednesday | News
COVID -19 Recommendations Map offers accessible pandemic guidelines

The RecMap is available here = https://covid19.recmap.org The RecMap is a one-stop shop for clinical, public health and health policy COVID-19 recommendat...

April 12, 2023 | Wednesday | News
Science 37 Unveils Three Global Centers of Excellence to Drive Efficiency, Speed and Quality

- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today unveiled three global Centers of Excellence (COEs) to gain greater ...

April 12, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close